US Stock MarketDetailed Quotes
DERM Journey Medical
- 3.540
- 0.0000.00%
Close Apr 23 16:00 ET
- 3.420
- -0.120-3.39%
Post 16:34 ET
70.56MMarket Cap-16857P/E (TTM)
3.590High3.450Low75.36KVolume3.500Open3.540Pre Close265.05KTurnover0.91%Turnover RatioLossP/E (Static)19.93MShares8.11052wk High3.47P/B29.20MFloat Cap1.02052wk Low--Dividend TTM8.25MShs Float10.200Historical High--Div YieldTTM3.96%Amplitude1.020Historical Low3.517Avg Price1Lot Size
About Journey Medical Company
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Company Profile
SymbolDERM
Company NameJourney Medical
Listing DateNov 12, 2021
Issue Price10.00
Founded2014
CEOMr. Claude Maraoui
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9237 E Via de Ventura Boulevard,Suite 105
CityScottsdale
ProvinceArizona
CountryUnited States of America
Zip Code85258
Phone1-480-434-6670
Company Executives
- Name
- Position
- Salary
- Claude Maraoui
- Director, President and Chief Executive Officer
- 1.87M
- Joseph Benesch
- Corporate Controller and Interim Chief Financial Officer
- --
- Dr. Lindsay A. Rosenwald, M.D.
- Executive Chairman of the Board
- 100.00K
- Miranda Jayne Toledano
- Independent Director
- 253.30K
- Neil Herskowitz
- Independent Director
- 263.30K
- Justin Smith
- Independent Director
- 253.30K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg